Neurobit uses sleep as a biomarker across age, gender and race to predict and prevent adverse health outcomes well before they happen.
Neurobit has raised $100K in total funding. The most recent round was Angel. The last funding was announced in April 2023.
Neurobit's investors include Entrepreneurs First, Enterprise Singapore, iHealthtech, NUS.
Neurobit is headquartered in New York, United States.
Neurobit uses sleep as a biomarker across age, gender and race to predict and prevent adverse health outcomes well before they happen.
Neurobit is at the Angel stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurobit — Funding & Investors." VCBacked, April 1, 2023, https://www.vcbacked.co/company/neurobit. Accessed July 19, 2026.
VCBacked. (2023). Neurobit — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neurobit
{{cite web |title=Neurobit — Funding & Investors |url=https://www.vcbacked.co/company/neurobit |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated